Picture of Indivior logo

INDV — Indivior News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Director/PDMR Shareholding

RNS Number : 2015A

Indivior PLC

11 March 2025

 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that it received notification on March 10, 2025 that Dr. Keith Humphreys, a Non-Executive Director of the Company, acquired a total of 1,500 Ordinary Shares of US$0.50 each in the Company ('Shares') at an average price of $9.149 per Share on March 10, 2025.

Following this transaction, Dr. Keith Humphreys has an interest in 3,879 Shares in the Company.

 

1Details of the person discharging managerial responsibilities / person closely associated
a)NameKeith Humphreys
2Reason for the notification
a)Position/statusNon-Executive Director / PDMR
b)Initial notification /AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameIndivior PLC
b)LEI213800V3NCQTY7IED471
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of US$0.50
GB00BN4HT335
b)Nature of the transactionPurchase of Shares
c)Price(s) and volume(s)
Price(s)Volume(s)
$9.1491,500
d)Aggregated information
- Aggregated volume
- Price
N/A
e)Date of the transactionMarch 10, 2025
f)Place of the transactionNasdaq Global Select Market
    This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     DSHGPUMGWUPAGUG

Recent news on Indivior

See all news